If 10mg Mounjaro Isn't Working, Here's What to Check First

What trial data actually shows about weight loss at 10mg

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed adults with obesity over 72 weeks. One pattern is consistent across the dosing arms: weight loss does not arrive in a straight line. Participants often lost weight steadily, then hit a slower phase, then lost more. A plateau mid-treatment was the norm, not the exception.

At 10mg, average reductions were meaningful but typically below the 20–21% seen at 15mg. That gap is deliberate, the escalation schedule exists precisely because some people need the higher doses to unlock the full physiological effect. So if 10mg Mounjaro isn't working as well as expected, one clinically supported explanation is simply that 15mg is where your response lives.

It is also worth knowing that the concept of a "golden dose" varies between individuals. A dose that produces 18% weight loss in one person may produce 8% in another, for reasons rooted in genetics, gut-hormone baseline and metabolic rate, none of which are visible from outside.

The things worth checking before you assume the dose has failed

Before concluding that 10mg has stopped working, there are a few practical things worth examining. First: injection technique. Tirzepatide is a subcutaneous injection, and it must reach the fatty tissue beneath the skin, not muscle, not skin-surface. The NHS tirzepatide guidance notes rotating sites (abdomen, thigh, upper arm) matters, partly because repeatedly using the same spot can create scar tissue that slows absorption.

Second: storage. Tirzepatide pens must be kept refrigerated at 2–8°C. A pen that has been left at room temperature longer than the SmPC permits may have degraded, reducing how much active medicine you actually received. The pen should feel cold from the fridge, that's a 30-second check worth doing every time.

Third: dietary pattern. The medicine reduces appetite significantly, but protein intake matters. If calories have dropped so low that muscle mass is being lost alongside fat, the metabolic rate can fall, and the scale slows. This is not a medicine failure, it is a diet composition question your prescriber or a dietitian can help with.

If the lower doses have featured in your journey, reading about why the starting 2.5mg dose can sometimes feel ineffective gives useful context here too, many of the same physiological mechanisms apply. You may also find it helpful to read about why 5mg may not have worked for some patients.

When titrating to 15mg is the right clinical discussion

If you have been on 10mg for at least four weeks, tolerated it without significant side effects, and weight loss has clearly stalled, the licensed next step is 12.5mg, then 15mg. 15mg is the highest licensed dose, and in SURMOUNT-1 it produced the greatest average weight reductions observed in the trial programme. Some patients only achieve meaningful momentum at that level.

This is not a decision to make alone. Your prescriber needs to review your current weight, your tolerance of 10mg, and any other factors in your health picture. If you are being treated privately, that conversation should be easy to initiate, and at a clinician-led service like ours, every repeat and every dose increase is individually reviewed. Evidence of your current dose and recent weight is required before any change is approved; that is a patient safety step, not a barrier.

For context on what the full dosing journey can look like, the Mounjaro treatment overview sets out the licensed schedule from 2.5mg to 15mg clearly. Cost questions sometimes arise around higher doses, the Mounjaro pricing page explains what drives private costs at each strength.

When to speak to a prescriber urgently versus routinely

A weight plateau is rarely an emergency. It is a signal for a scheduled clinical conversation. There are, however, circumstances where you should seek medical advice without delay: severe or persistent stomach pain that spreads to your back (which can indicate pancreatitis), signs of an allergic reaction, or any new symptom that concerns you. You can report unexpected side effects directly through the MHRA Yellow Card scheme.

For the more common situation (the dose is tolerated, but weight loss has slowed) the right move is a routine review. Bring your weight records if you have them. Note when the plateau started and roughly what your diet and activity have looked like. A good prescriber will use all of that. If you want a fresh clinical perspective, starting a consultation with our prescribers is free, and you'll hear from a clinician the same day.